« Back
Home /
Vandetanib

Vandetanib

Item no.	TMO-T1656-2mg
Manufacturer	TargetMol
CASRN	443913-73-3
Amount	2mg
Category	Oncology Neuroscience Neural Signaling Reagents & Chemicals Molecules By Organ Bladder Cancer
Type	Molecules
Specific against	other
Purity	0,98
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	Vandetanib, Zactima; ZD6474; ZD-6474; ZD 6474
Similar products	443913-73-3
Available
Description	Vandetanib is an orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), thereby blocking VEGF-stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability. This agent also blocks the tyrosine kinase activity of epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that mediates tumor cell proliferation and migration and angiogenesis.
Formulate	C22H24BrFN4O2
Shipping temperature	Cool Pack
Smeles	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3 =C(F)C=C(Br)C=C3)C2=C1
Storage Temperature	-20° C

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 2mg

available

Delivery expected until 9/6/2024

Express Delivery: Save 3 days

Compare

Add to wishlist

Recommend by mail